Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review
<b>Background</b>: Giant cell tumor of bone (GCTB) is a locally aggressive tumor. It accounts for only 5% of all bony tumors. Early diagnosis, and follow-up for recurrence is often difficult due to a lack of biogenetic markers. Giant cells are multinucleated epithelioid cells derived fro...
Saved in:
| Main Authors: | Muhammad Taqi, Haseeb ul Rasool, Mobeen Zaka Haider, Munjed Al Muderis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/1/39 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tenosynovial giant cell tumor of hand: A rare case report
by: Dr C.S. Shreyas, et al.
Published: (2025-03-01) -
Clinical Audit of Denosumab Biosimilar for Aggressive GCT of Bone: A Tertiary Care Center Retrospective Analysis
by: Rajesh B. Singh, et al. -
Research on the Isolation Technology for Reverse Conducting IGCT
by: CHEN Fanglin, et al.
Published: (2015-01-01) -
Optimization of the buffer layer in a 15kV SiC N-type gate commutated thyristor for safe, low-loss switching
by: Qinze Cao, et al.
Published: (2025-06-01) -
A New Drive Circuit Topology for GCT Turning-on
by: ZENG Hong, et al.
Published: (2015-01-01)